Skip to content
Vision Culture UK

Providing Stem Cells in Utero to Infants with Spina Bifida Boosts Life Outcomes, Trial Finds

A groundbreaking clinical study has found that providing pluripotent cells to unborn babies suffering from spina bifida while undergoing fetal surgery can be a "major milestone" in managing prenatal disorders.

Trial Details and Safety

The American study involved six fetuses with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells on the exposed area of the baby's spinal cord while the defect was being closed.

Significantly, the stem cell application was found to be safe. Researchers confirmed that the therapy did not induce cancerous growths, hinder surgical recovery, or block the correction of co-occurring hindbrain herniation.

Positive Developments

Post-birth MRI scans confirmed a complete reversal of Chiari malformation in each of the babies. This favorable anatomical change is a key indicator for improved motor skills and quality of life.

"Should it enable a greater number of infants to achieve ambulation who wouldn't have, then it would become the new treatment paradigm," said the lead researcher. "The results are super exciting and pave the way for a variety of prospective novel therapies."

Future Implications and Hope

Commentators reviewing the findings have suggested that additional validation of these noted improvements could announce a "fresh chapter" in fetal surgery. The potential to improve neurological damage occurring during fetal development is regarded as a revolutionary objective.

Particularly welcome would be advancements for continence and digestive health, which are frequent complications for those diagnosed with this condition.

The Path Forward

While this initial trial focused on a handful of cases, its confirmed tolerability and hopeful trends provide a strong foundation for broader investigative efforts. The combination of regenerative medicine with established fetal surgery techniques offers substantial hope for improving the prognosis for future generations with myelomeningocele.

Written by

Joseph Henry

Elara Vance is a London-based art critic and curator with over a decade of experience in visual arts and cultural commentary.

Vision Culture UK

Type to search articles.